Clinical Trials Logo

Clinical Trial Summary

This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06214039
Study type Interventional
Source Vilnius University
Contact Jonas Eimontas, PhD
Phone +37052667615
Email jonas.eimontas@fsf.vu.lt
Status Recruiting
Phase N/A
Start date February 14, 2024
Completion date May 2026

See also
  Status Clinical Trial Phase
Completed NCT00000370 - Treatment of Social Phobia N/A